title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
This Biotech Just Barreled Into Its 50-Day Line - Here's Why,https://www.investors.com/news/technology/ptc-stock-flashes-a-bearish-sign-after-european-officials-reject-dmd-drug/,2024-01-26 15:18:00,PTC Stock Flashes A Bearish Sign After European Officials Reject DMD Drug Investor's Business Daily ...,RMD,0.080188,-0.329682,Somewhat-Bearish
Here's Why ResMed  ( RMD )  is a Strong Momentum Stock,https://www.zacks.com/stock/news/2216534/heres-why-resmed-rmd-is-a-strong-momentum-stock,2024-01-26 14:50:06,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",RMD,0.565345,0.200065,Somewhat-Bullish
Why ResMed Stock Is Jumping Today,https://www.fool.com/investing/2024/01/25/why-resmed-stock-is-jumping-today/,2024-01-25 17:07:03,The medical device maker beat expectations with its latest quarterly results.,RMD,0.672055,0.390165,Bullish
"ResMed  ( RMD )  Q2 Earnings Beat Estimates, Margins Expand",https://www.zacks.com/stock/news/2216027/resmed-rmd-q2-earnings-beat-estimates-margins-expand,2024-01-25 17:04:00,ResMed's (RMD) Q2 results reflect cost discipline to support an acceleration in profitability.,RMD,0.291182,-0.012662,Neutral
Digital Health Stock Flies Above Its 200-Day Line On Strong Beat,https://www.investors.com/news/technology/rmd-stock-soars-above-its-200-day-after-flexing-its-operating-muscle/,2024-01-25 14:03:00,RMD Stock Soars Above Its 200-Day Line After Flexing Its 'Operating Muscle' Investor's Business Daily ...,RMD,0.674691,0.306707,Somewhat-Bullish
"AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday - Covenant Logistics Gr  ( NASDAQ:CVLG ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/news/24/01/36777733/at-t-to-rally-around-44-here-are-10-top-analyst-forecasts-for-thursday,2024-01-25 12:42:44,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised ResMed Inc. RMD price target from $180 to $215. Needham analyst Mike Matson maintained a Buy ...",RMD,0.245339,-0.039598,Neutral
ResMed  ( RMD )  Tops Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2215273/resmed-rmd-tops-q2-earnings-and-revenue-estimates,2024-01-24 22:25:05,"ResMed (RMD) delivered earnings and revenue surprises of 3.87% and 0.46%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?",RMD,0.401331,0.247315,Somewhat-Bullish
The 4 most important things we're watching in the stock market this coming week,https://www.cnbc.com/2024/01/20/4-most-important-things-were-watching-in-the-stock-market-this-week.html,2024-01-20 15:13:48,On tap: A handful of key economic updates and a ramp up of quarterly earnings reports.,RMD,0.042234,0.0,Neutral
Stay Ahead of the Game With ResMed  ( RMD )  Q2 Earnings: Wall Street's Insights on Key Metrics,https://www.zacks.com/stock/news/2213008/stay-ahead-of-the-game-with-resmed-rmd-q2-earnings-wall-streets-insights-on-key-metrics,2024-01-19 18:05:00,"Evaluate the expected performance of ResMed (RMD) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",RMD,0.396261,0.194828,Somewhat-Bullish
Nyxoah Announces 2024 Strategic Priorities,https://www.globenewswire.com/news-release/2024/01/17/2811118/0/en/Nyxoah-Announces-2024-Strategic-Priorities.html,2024-01-17 21:05:00,"Mont-Saint-Guibert, Belgium - January 17, 2024, 10:05pm CET / 4:05pm ET - Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) ( ""Nyxoah"" or the ""Company"" ) , a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ( OSA ) , ...",RMD,0.065061,0.066312,Neutral
Nyxoah Announces 2024 Strategic Priorities - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/24/01/g36667929/nyxoah-announces-2024-strategic-priorities,2024-01-17 21:05:00,"Mont-Saint-Guibert, Belgium - January 17, 2024, 10:05pm CET / 4:05pm ET - Nyxoah SA NYXH ( ""Nyxoah"" or the ""Company"" ) , a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ( OSA ) , today announced, in ...",RMD,0.063594,0.037141,Neutral
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2211621/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2024-01-17 17:05:00,Investors are optimistic about ResMed (RMD) on strong uptake of the myAir app with AirSense11.,RMD,0.154785,0.14276,Neutral
Here's Why ResMed  ( RMD )  is a Strong Growth Stock,https://www.zacks.com/stock/news/2211437/heres-why-resmed-rmd-is-a-strong-growth-stock,2024-01-17 14:45:08,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",RMD,0.496915,0.354916,Bullish
NOCTRIX HEALTH SECURES $40 MILLION SERIES C FINANCING TO COMMERCIALIZE NOVEL DEVICE ... - PR Newswire,https://www.prnewswire.com/news-releases/noctrix-health-secures-40-million-series-c-financing-to-commercialize-novel-device-treatment-for-restless-legs-syndrome-rls-302035397.html,2024-01-16 14:15:00,NOCTRIX HEALTH SECURES $40 MILLION SERIES C FINANCING TO COMMERCIALIZE NOVEL DEVICE ... PR ...,RMD,0.067158,0.073765,Neutral
"Smart Inhalers Market Will Reach US$ 235.7 Million by 2033, By Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36635742/smart-inhalers-market-will-reach-us-235-7-million-by-2033-by-persistence-market-research,2024-01-16 10:15:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Smart Inhalers Market: A Breath of Fresh Air for Healthcare Smart Inhalers are inhalation devices equipped with sensors and connectivity features to monitor and manage respiratory conditions, such as asthma and chronic obstructive pulmonary ...",RMD,0.015978,0.297061,Somewhat-Bullish
Sleep Apnea Diagnostic and Therapeutic Devices Market size to grow by USD 3.29 billion from 2022 to 2027; The ... - PR Newswire,https://www.prnewswire.com/news-releases/sleep-apnea-diagnostic-and-therapeutic-devices-market-size-to-grow-by-usd-3-29-billion-from-2022-to-2027-the-increasing-early-detection-of-sleep-apnea-disorders-to-boost-the-market--technavio-302034464.html,2024-01-16 07:35:00,Sleep Apnea Diagnostic and Therapeutic Devices Market size to grow by USD 3.29 billion from 2022 to 2027. The ... PR ...,RMD,0.05339,0.063736,Neutral
Salon CES 2024 : la plateforme mondiale qui définit notre avenir,https://www.prnewswire.com/news-releases/salon-ces-2024--la-plateforme-mondiale-qui-definit-notre-avenir-302034370.html,2024-01-15 04:55:00,"LAS VEGAS, 15 janvier 2024 /PRNewswire/ -- Le salon CES® 2024 s'est achevé aujourd'hui, après une semaine exaltante qui a défini le parcours technologique pour l'année à venir.",RMD,0.017928,-0.027073,Neutral
CES 2024: The Global Platform Defining Our Future,https://www.prnewswire.com/in/news-releases/ces-2024-the-global-platform-defining-our-future-864500861.html,2024-01-13 00:54:00,"Tech Execs and Global Leaders Choose CES for AI, Accessibility, Digital Health and Mobility LAS VEGAS, Jan. 13, 2024 /PRNewswire/ -- CES® 2024 closes today, after an exhilarating week that set the technology narrative for the year ahead.",RMD,0.025139,0.122363,Neutral
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/large-cap/24/01/36612063/fda-identifies-resmeds-recall-of-certain-ventilator-device-masks-with-magnets-as-most-serious,2024-01-12 15:07:13,"Thursday, ResMed Ltd RMD said it is recalling some of its Continuous Positive Airway Pressure ( CPAP ) masks with magnets due to possible magnetic interference with certain medical devices.",RMD,0.616447,0.090177,Neutral
"If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/news/24/01/36580201/if-you-invested-100-in-this-stock-15-years-ago-you-would-have-900-today,2024-01-10 17:00:22,"ResMed RMD has outperformed the market over the past 15 years by 3.76% on an annualized basis producing an average annual return of 15.97%. Currently, ResMed has a market capitalization of $25.95 billion.",RMD,0.983605,0.387251,Bullish
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/24/01/g36565607/nyxoah-announces-preliminary-results-for-the-fourth-quarter-and-full-year-2023,2024-01-09 21:05:00,"Mont-Saint-Guibert, Belgium - January 9, 2024, 10:05pm CET / 4:05pm ET - Nyxoah SA NYXH ( ""Nyxoah"" or the ""Company"" ) , a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ( OSA ) , today announced certain ...",RMD,0.080323,0.058616,Neutral
Top 2024 Picks From MoneyShow's Roster of Expert Contributors,https://www.forbes.com/sites/moneyshow/2024/01/08/top-2024-picks-from-moneyshows-roster-of-expert-contributors/,2024-01-08 17:48:55,"Every year for the past few decades, MoneyShow has reached out to their most respected, time-tested analysts, strategists, and newsletter editors to get their favorite stock, ETF, and other investments for the coming 12 months. The annual MoneyShow Top Picks report is the result of this project.",RMD,0.169335,0.100418,Neutral
"Respiratory Devices Market Size to be Worth USD 37.7 billion by 2031, with Notable CAGR of 6.1%| Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36533244/respiratory-devices-market-size-to-be-worth-usd-37-7-billion-by-2031-with-notable-cagr-of-6-1-tran,2024-01-08 13:44:48,"Wilmington, Delaware, United States, Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global respiratory devices market is estimated to flourish at a CAGR of 6.1% from 2023 to 2031.",RMD,0.065238,0.216571,Somewhat-Bullish
Lo que nadie puede perderse en CES 2024 - PR Newswire,https://www.prnewswire.com/news-releases/lo-que-nadie-puede-perderse-en-ces-2024-850793074.html,2024-01-08 02:42:00,Lo que nadie puede perderse en CES 2024 PR ...,RMD,0.061315,0.05,Neutral
Was Sie auf der CES 2024 nicht verpassen sollten - PR Newswire,https://www.prnewswire.com/news-releases/was-sie-auf-der-ces-2024-nicht-verpassen-sollten-302027920.html,2024-01-08 01:45:00,Was Sie auf der CES 2024 nicht verpassen sollten PR ...,RMD,0.06623,-0.124836,Neutral
O que não perder na CES 2024 - PR Newswire,https://www.prnewswire.com/news-releases/o-que-nao-perder-na-ces-2024-876442842.html,2024-01-07 19:56:00,O que não perder na CES 2024 PR ...,RMD,0.068502,0.061161,Neutral
What Not to Miss at CES 2024 - Canada NewsWire,https://www.newswire.ca/news-releases/what-not-to-miss-at-ces-2024-848006699.html,2024-01-04 21:35:00,What Not to Miss at CES 2024 Canada ...,RMD,0.104683,0.191406,Somewhat-Bullish
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference,https://www.globenewswire.com/news-release/2023/12/27/2801518/0/en/ResMed-Announces-Participation-in-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html,2023-12-27 21:05:00,"SAN DIEGO, Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, beginning at approximately 2:15 p.m. ( Pacific ...",RMD,0.880186,0.534642,Bullish
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/12/g36404317/resmed-announces-participation-in-the-42nd-annual-j-p-morgan-healthcare-conference,2023-12-27 21:05:00,"SAN DIEGO, Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- ResMed RMDRMD ) ) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P.",RMD,0.612033,0.462125,Bullish
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/23/12/36380226/1000-invested-in-resmed-15-years-ago-would-be-worth-this-much-today,2023-12-25 21:00:20,"ResMed RMD has outperformed the market over the past 15 years by 4.34% on an annualized basis producing an average annual return of 16.13%. Currently, ResMed has a market capitalization of $25.21 billion.",RMD,0.983605,0.387251,Bullish
 ( RMD )  - Analyzing ResMed's Short Interest - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/short-sellers/23/12/36360406/rmd-analyzing-resmeds-short-interest,2023-12-22 13:00:19,"ResMed's RMD short percent of float has fallen 7.16% since its last report. The company recently reported that it has 5.85 million shares sold short, which is 4.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.67 days to cover their ...",RMD,0.224903,0.085754,Neutral
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices,https://www.globenewswire.com/news-release/2023/12/20/2799639/0/en/ResMed-Notifies-Customers-About-Updated-Instructions-and-Labeling-for-Masks-with-Magnets-Due-to-Potential-Interference-with-Certain-Medical-Devices.html,2023-12-20 21:05:00,ResMed's masks with magnets are safe when used in accordance with the updated Instructions for Use ResMed's masks with magnets are safe when used in accordance with the updated Instructions for Use ...,RMD,0.831914,0.066012,Neutral
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/12/g36333824/resmed-notifies-customers-about-updated-instructions-and-labeling-for-masks-with-magnets-due-to-po,2023-12-20 21:05:00,"SAN DIEGO, Dec. 20, 2023 ( GLOBE NEWSWIRE ) -- ResMed RMDRMD ) ) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body.",RMD,0.678981,0.056935,Neutral
"If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/news/23/12/36237872/if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-17-000-today,2023-12-14 14:31:13,"ResMed RMD has outperformed the market over the past 20 years by 7.47% on an annualized basis producing an average annual return of 15.05%. Currently, ResMed has a market capitalization of $25.31 billion.",RMD,0.983605,0.387251,Bullish
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2196711/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2023-12-12 14:19:00,Investors continue to be optimistic about ResMed (RMD) due to the sustained growth in the SaaS business.,RMD,0.196451,0.159024,Somewhat-Bullish
ResMed Secures Significant Victory in Patent Fight Against New York University,https://www.globenewswire.com/news-release/2023/12/11/2794261/0/en/ResMed-Secures-Significant-Victory-in-Patent-Fight-Against-New-York-University.html,2023-12-11 21:05:00,"SAN DIEGO, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board ( PTAB ) invalidated the claims New York University ( NYU ) asserted against ResMed, based on seven NYU patents.",RMD,0.876064,0.411411,Bullish
ResMed Secures Significant Victory in Patent Fight Against New York University - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/12/g36185026/resmed-secures-significant-victory-in-patent-fight-against-new-york-university,2023-12-11 21:05:00,"SAN DIEGO, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- ResMed RMDRMD ) ) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board ( PTAB ) invalidated the claims New York University ( NYU ) asserted against ResMed, based on seven NYU patents.",RMD,0.686739,0.37078,Bullish
"The Ultimate CES 2024 Guide To The Hottest Parties, Panels And Robots",https://www.forbes.com/sites/martineparis/2023/12/07/the-ultimate-ces-2024-guide-to-the-hottest-parties-panels-and-robots/,2023-12-08 02:29:18,"Cruise the home of the future, chat with a refrigerator, play ping pong with a robot, enjoy autonomous rides and party with Ludacris. The world's most exciting technology show is gearing up to descend on Las Vegas, the week of January 7, with more than 130,000 attendees and 2.3 million net square ...",RMD,0.020215,0.081803,Neutral
"Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally",https://www.globenewswire.com/news-release/2023/12/07/2792869/0/en/Study-Estimates-a-23-Increase-in-COPD-by-2050-Representing-600-Million-Patients-Globally.html,2023-12-07 20:34:00,"New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.",RMD,0.450695,0.144602,Neutral
Why ResMed  ( RMD )  is a Top Momentum Stock for the Long-Term,https://www.zacks.com/stock/news/2194820/why-resmed-rmd-is-a-top-momentum-stock-for-the-long-term,2023-12-07 14:50:07,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",RMD,0.622414,0.21038,Somewhat-Bullish
"Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37 ... - PR Newswire",https://www.prnewswire.com/news-releases/smart-inhaler-technology-market-size-to-grow-by-usd-46-37-million-from-2022-2027--north-america-to-account-for-37-of-market-growth---technavio-302002805.html,2023-12-01 23:15:00,"Smart Inhaler Technology Market size to grow by USD 46.37 million from 2022-2027, North America to account for 37 ... PR ...",RMD,0.064623,0.0,Neutral
Envista  ( NVST )  Up 6.8% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2192353/envista-nvst-up-68-since-last-earnings-report-can-it-continue,2023-12-01 16:32:02,Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,RMD,0.222838,0.025505,Neutral
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2192208/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick,2023-12-01 14:45:08,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",RMD,0.514619,0.361961,Bullish
Elevating Workplace Inclusion: Leading Companies Embrace myGwork Academy's Award-Winning Allyship Course,https://www.prnewswire.com/news-releases/elevating-workplace-inclusion-leading-companies-embrace-mygwork-academys-award-winning-allyship-course-302002289.html,2023-11-30 15:56:00,"LONDON, Nov. 30, 2023 /PRNewswire/ -- In an era where workplace inclusivity and allyship are pivotal for organisational success, the myGwork Academy's award-winning e-learning course on allyship is providing much-needed training for companies to foster more inclusive environments.",RMD,0.048327,0.10796,Neutral
Continuous positive airway pressure (CPAP) market in US to grow by USD 428.84 million from 2023 to 2028; Rising ... - PR Newswire,https://www.prnewswire.com/news-releases/continuous-positive-airway-pressure-cpap-market-in-us-to-grow-by-usd-428-84-million-from-2023-to-2028-rising-demand-for-home-care-settings-is-the-primary-trend-shaping-market-growth---technavio-301991612.html,2023-11-17 19:30:00,Continuous positive airway pressure ( CPAP ) market in US to grow by USD 428.84 million from 2023 to 2028. Rising ... PR ...,RMD,0.067919,0.0,Neutral
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion - Tesla  ( NASDAQ:TSLA ) ,https://www.benzinga.com/markets/equities/23/11/35843401/senators-bearish-tesla-bet-under-scrutiny-as-he-buys-put-options-ahead-of-elon-musk-led-companys,2023-11-17 07:02:36,"Tesla, Inc. TSLA shares have been going through a lean phase and the modest recovery seen has been in fits-and-starts. Against this backdrop, a Congressman has disclosed on Thursday bearish bets on the electric vehicle giant. What Happened: Sen.",RMD,0.135347,0.0,Neutral
ResMed Unusual Options Activity For November 10 - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/markets/options/23/11/35732216/resmed-unusual-options-activity-for-november-10,2023-11-10 19:01:46,"Benzinga's options scanner has just identified more than 12 option transactions on ResMed RMD, with a cumulative value of $669,835. Concurrently, our algorithms picked up 4 puts, worth a total of 153,348.",RMD,0.640349,0.330727,Somewhat-Bullish
ResMed Adopts New Operating Model to Accelerate Long-term Growth - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/11/g35712068/resmed-adopts-new-operating-model-to-accelerate-long-term-growth,2023-11-09 21:05:00,"Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue Officer, effective immediately. Rob Douglas, President and Chief Operating Officer, to retire January 1, 2024.",RMD,0.395012,0.520757,Bullish
"Passover Humidifiers Market to Hit USD 73.9 billion by 2031, Rising at a 2.1% CAGR: TMR  ( Analysis, Outlook, Leaders, Forecast, Growth ) ",https://www.benzinga.com/pressreleases/23/11/g35693016/passover-humidifiers-market-to-hit-usd-73-9-billion-by-2031-rising-at-a-2-1-cagr-tmr-analysis-outl,2023-11-09 07:26:02,"Wilmington, Delaware, United States, Nov. 09, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global passover humidifiers market is projected to flourish at a CAGR of 2.1% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 73.9 million is anticipated for ...",RMD,0.130689,0.084381,Neutral
Corporate America weighs business impact of new weight-loss drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-business-impact-new-weight-loss-drugs-2023-11-08/,2023-11-08 18:19:00,"[1/3] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",RMD,0.054114,0.004,Neutral
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio,https://www.zacks.com/stock/news/2180067/why-this-1-growth-stock-could-be-a-great-addition-to-your-portfolio,2023-11-07 14:45:07,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,RMD,0.493128,0.353409,Bullish
2 Monster Stocks to Buy Without Any Hesitation,https://www.fool.com/investing/2023/11/07/2-monster-stocks-to-buy-without-any-hesitation/,2023-11-07 10:05:00,"Down 33% and 44%, these two stocks look too good to pass up today.",RMD,0.240149,0.123234,Neutral
Sleep Apnea Diagnostic And Therapeutic Devices Market size to grow by USD 3.29 billion from 2022-2027| APEX ... - PR Newswire,https://www.prnewswire.com/news-releases/sleep-apnea-diagnostic-and-therapeutic-devices-market-size-to-grow-by-usd-3-29-billion-from-2022-2027-apex-medical-corp-asahi-kasei-corp-bmc-medical-co-ltd-and-more-among-the-key-market-companies--technavio-301978050.html,2023-11-06 23:15:00,Sleep Apnea Diagnostic And Therapeutic Devices Market size to grow by USD 3.29 billion from 2022-2027| APEX ... PR ...,RMD,0.06179,0.013,Neutral
"How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In - ResMed  ( NYSE:RMD ) , Koninklijke Philips  ( NYSE:PHG ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35471750/how-sleep-device-player-resmed-is-gaining-philips-market-share-in-flow-generator-ma,2023-10-27 19:34:33,"Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. RMD with a price target of $180. ResMed registered a street-beating performance in the first quarter, where revenue increased by 16% to $1.1 billion. ResMed is benefiting from the Koninklijke Philips N.V.'s PHG flow generator ...",RMD,0.907478,0.23853,Somewhat-Bullish
Weight-Loss Beating Continues For Devices Makers; Why It's Overdone,https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/,2023-10-27 13:00:00,Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...,RMD,0.034907,0.125221,Neutral
"ResMed  ( RMD )  Q1 Earnings Surpass Estimates, Margins Down",https://www.zacks.com/stock/news/2173533/resmed-rmd-q1-earnings-surpass-estimates-margins-down,2023-10-27 12:01:00,ResMed's (RMD) solid revenue growth in the first quarter of fiscal 2024 reflects the strength of AirSense 10 and AirSense 11 sleep devices and robust growth in the mask product portfolio.,RMD,0.330102,0.262173,Somewhat-Bullish
Analysis: Healthcare companies counter investor worries over Wegovy effect,https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-companies-counter-investor-worries-over-wegovy-effect-2023-10-27/,2023-10-27 05:00:20,"A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights",RMD,0.049221,0.003987,Neutral
ResMed  ( RMD )  Beats Q1 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2173137/resmed-rmd-beats-q1-earnings-and-revenue-estimates,2023-10-26 21:30:16,"ResMed (RMD) delivered earnings and revenue surprises of 0.61% and 0.51%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",RMD,0.400265,0.145597,Neutral
"Pediatric Home-use Medical Devices Market is Anticipated to Reach US$ 4.27 billion by 2031, Garnering 6.2% CAGR: TMR Report",https://www.benzinga.com/pressreleases/23/10/g35445700/pediatric-home-use-medical-devices-market-is-anticipated-to-reach-us-4-27-billion-by-2031-garnerin,2023-10-26 16:30:00,"Wilmington, Delaware, United States, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The pediatric home-use medical devices market was estimated to have acquired US$ 2.2 billion in 2021.",RMD,0.035768,0.276551,Somewhat-Bullish
ResMed  ( RMD )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release,https://www.zacks.com/stock/news/2168858/resmed-rmd-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release,2023-10-19 14:01:58,ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RMD,0.300088,0.059885,Neutral
104 million Indians may suffer from Obstructive Sleep Apnea; Here's what you need to know,https://www.financialexpress.com/healthcare/news-healthcare/104-million-indians-may-suffer-from-obstructive-sleep-apnea-heres-what-you-need-to-know/3274256/,2023-10-16 09:31:04,104 million Indians may suffer from Obstructive Sleep Apnea. Here's what you need to know The Financial Express ...,RMD,0.150122,-0.115845,Neutral
"Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday - Astria Therapeutics  ( NASDAQ:ATXS ) , Dynatrace  ( NYSE:DT ) ",https://www.benzinga.com/news/23/10/35218021/exxon-mobil-to-rally-around-23-here-are-10-other-analyst-forecasts-for-thursday,2023-10-12 12:21:51,Cantor Fitzgerald cut Hyliion Holdings Corp. HYLN price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell 1.4% to $0.6449 in pre-market trading. B of A Securities increased the price target for Target Corporation ...,RMD,0.270773,0.038147,Neutral
Australia's CSL tanks as Novo Nordisk's kidney trial success stokes competition concerns,https://www.reuters.com/business/healthcare-pharmaceuticals/australias-csl-tanks-novo-nordisks-kidney-trial-success-stokes-competition-2023-10-12/,2023-10-12 05:54:14,"Oct 12 ( Reuters ) - Shares of biotechnology firm CSL ( CSL.AX ) fell to a four-year low on Thursday, after rival Novo Nordisk's ( NOVOb.CO ) Ozempic drug showed early signs of success in delaying the progression of kidney disease in diabetes patients.",RMD,0.142565,-0.19268,Somewhat-Bearish
ResMed  ( RMD )  Gains From Strong Device Sales Amid Macro Woes,https://www.zacks.com/stock/news/2162750/resmed-rmd-gains-from-strong-device-sales-amid-macro-woes,2023-10-09 15:15:00,ResMed's (RMD) respiratory care business continues to drive growth and the adoption of bilevel and other non-invasive ventilator solutions worldwide.,RMD,0.263942,0.089451,Neutral
"Stocks making the biggest premarket moves: Pioneer Natural Resources, Levi Strauss, Tesla, Philips and more",https://www.cnbc.com/2023/10/06/stocks-making-the-biggest-premarket-moves-.html,2023-10-06 12:16:07,These are the stocks posting the largest moves in the premarket.,RMD,0.114137,0.04642,Neutral
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2159090/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2023-10-03 12:56:00,Investors continue to be optimistic about ResMed (RMD) due to the core business' performance and sustained growth in the SaaS business.,RMD,0.255195,0.323968,Somewhat-Bullish
Will ResMed Stock Rebound To Its Pre-Inflation Shock Highs Of $300?,https://www.forbes.com/sites/greatspeculations/2023/10/02/will-resmed-stock-rebound-to-its-pre-inflation-shock-highs-of-300/,2023-10-02 13:00:00,This compares with the Sharpe of 1.3 for the Trefis Reinforced Value portfolio.,RMD,0.588876,-0.116928,Neutral
"Here are 11 stocks Jim Cramer is watching, including Buffett's Berkshire and restaurant stocks",https://www.cnbc.com/2023/09/29/11-stocks-jim-cramer-is-watching-including-berkshire-restaurant-stocks.html,2023-09-29 14:17:31,"Here are some of the tickers on my radar for Friday, Sept. 29, taken directly from my reporter's notebook.",RMD,0.188193,0.188321,Somewhat-Bullish
Nyxoah Announces Partnership with ResMed in Germany,https://www.globenewswire.com/news-release/2023/09/28/2751654/0/en/Nyxoah-Announces-Partnership-with-ResMed-in-Germany.html,2023-09-28 20:30:00,Nyxoah Announces Partnership with ResMed in Germany Creates a continuum of care in the German obstructive sleep apnea market,RMD,0.241284,0.254136,Somewhat-Bullish
Nyxoah Announces Partnership with ResMed in Germany - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/09/g34987550/nyxoah-announces-partnership-with-resmed-in-germany,2023-09-28 20:30:00,Nyxoah Announces Partnership with ResMed in GermanyCreates a continuum of care in the German obstructive sleep apnea market,RMD,0.22951,0.242415,Somewhat-Bullish
ResMed  ( RMD )  Stock Jumps 3.8%: Will It Continue to Soar?,https://www.zacks.com/stock/news/2156871/resmed-rmd-stock-jumps-38-will-it-continue-to-soar,2023-09-28 10:03:00,ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.,RMD,0.597525,0.348628,Somewhat-Bullish
ResMed  ( RMD )  Gains From Mask Sales Amid Macro Headwinds,https://www.zacks.com/stock/news/2154875/resmed-rmd-gains-from-mask-sales-amid-macro-headwinds,2023-09-25 13:45:00,"ResMed's (RMD) respiratory care business continues to drive growth, courtesy of the adoption of bilevel and other non-invasive ventilator solutions worldwide.",RMD,0.308246,0.115557,Neutral
The disruptive effect of weight loss drugs like Ozempic could have surprising impacts on the stock market. Here are potential winners and losers.,https://markets.businessinsider.com/news/stocks/ozempic-wegovy-glp1-weight-loss-drugs-stock-market-winners-losers-2023-9,2023-09-24 12:30:00,Weight Loss Drugs Like Ozempic Could Have Surprising Stock Market Effects - Markets Insider ...,RMD,0.038101,-0.103818,Neutral
Medtech Makers Are Real Losers From Obesity Drugs,https://www.barrons.com/articles/weight-loss-drugs-obesity-eli-lilly-novo-nordisk-bcd3dd6e,2023-09-21 05:00:00,Weight-Loss Drugs Are Bad News for Companies That Treat Obesity ... ...,RMD,0.414559,0.161174,Somewhat-Bullish
"Durable Medical Equipment Market Size to Hit $291.52 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/09/g34765157/durable-medical-equipment-market-size-to-hit-291-52-billion-globally-by-2027-exclusive-report-by-t,2023-09-20 14:29:23,"Pune, India, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Durable Medical Equipment Market Forecast to 2027 - Global Analysis - by Device Type ( Personal Mobility Devices and Monitoring & Therapeutic Devices ) and End User ( Hospitals & Clinics, Ambulatory Care ...",RMD,0.037622,0.183834,Somewhat-Bullish
ResMed Unusual Options Activity For September 15 - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/markets/options/23/09/34620079/resmed-unusual-options-activity-for-september-15,2023-09-15 15:33:29,"Someone with a lot of money to spend has taken a bearish stance on ResMed RMD. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",RMD,0.735697,0.145268,Neutral
"IoT Medical Devices Market Size is projected to reach USD 112 billion by 2031, growing at a CAGR of 27.6%: Straits Research",https://www.benzinga.com/pressreleases/23/09/g34583244/iot-medical-devices-market-size-is-projected-to-reach-usd-112-billion-by-2031-growing-at-a-cagr-of,2023-09-14 14:15:00,"New York, United States, Sept. 14, 2023 ( GLOBE NEWSWIRE ) -- IoT medical devices manage mechanical ventilation systems and artificial airways, disperse aerosol-based medications, and identify and treat cardiopulmonary diseases.",RMD,0.05339,0.044883,Neutral
Looking At ResMed's Recent Unusual Options Activity - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/markets/options/23/09/34456862/looking-at-resmeds-recent-unusual-options-activity,2023-09-11 20:15:55,"Someone with a lot of money to spend has taken a bullish stance on ResMed RMD. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",RMD,0.812186,0.449311,Bullish
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?,https://www.fool.com/investing/2023/09/07/is-it-time-to-buy-the-sp-500s-3-worst-performing-a/,2023-09-07 13:56:00,The S&P 500 had a rare decline last month.,RMD,0.142989,0.046297,Neutral
Sleep Device Player ResMed's Potential Obstacles: Analyst Weighs Obesity Drugs & Philips' Re-Entry - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/09/34286819/sleep-device-player-resmeds-potential-obstacles-analyst-weighs-obesity-drugs-philip,2023-09-06 18:39:34,"Needham upgraded ResMed Inc RMD from a Hold to Buy rating with a price target of $180. The analysts Mike Matson, Joseph Conway, and David Saxon note that ResMed's shares are down 31% since the start of August ( versus a 2% decline in the S&P 500 ) , mainly due to concerns about the potential for ...",RMD,0.62523,0.472418,Bullish
"Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more",https://www.cnbc.com/2023/09/06/stocks-making-the-biggest-moves-premarket-enb-roku-gtlb.html,2023-09-06 12:21:54,These are the companies making headlines in premarket trading on Wednesday.,RMD,0.12546,0.04191,Neutral
"American Express To Rally Over 25%? Here Are 10 Other Analyst Forecasts For Tuesday - American Express  ( NYSE:AXP ) , Centene  ( NYSE:CNC ) ",https://www.benzinga.com/news/23/09/34232793/american-express-to-rally-over-25-here-are-10-other-analyst-forecasts-for-tuesday,2023-09-05 12:19:43,"Wells Fargo raised the price target for Equity Residential EQR from $62 to $69. Wells Fargo analyst James Feldman upgraded the stock from Equal-Weight to Overweight. Equity Residential shares rose 0.6% to $64.39 in pre-market trading. B. Riley Securities cut 5E Advanced Materials, Inc.",RMD,0.268786,-0.160468,Somewhat-Bearish
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy,https://www.fool.com/investing/2023/09/01/3-reasons-resmeds-ceo-isnt-worried-about-ozempic-o/,2023-09-01 10:21:00,Mick Farrell might be kidding himself about the degree to which the popular weight-loss drugs will impact his company.,RMD,0.294345,-0.033133,Neutral
"3 Growth Stocks That Can Soar 50%, According to Wall Street",https://www.fool.com/investing/2023/08/25/3-growth-stocks-that-can-soar-50-according-to-wall/,2023-08-25 12:15:00,Are these stocks the slam-dunk buys analysts think they are?,RMD,0.268294,0.195138,Somewhat-Bullish
"AI Eye: Get better results being nice to ChatGPT, AI fake child porn debate, Amazon's AI reviews",https://cointelegraph.com/magazine/ai-eye-better-results-being-nice-to-chatgpt-ai-fake-child-porn-debate-amazons-ai-reviews/,2023-08-24 13:30:00,"There's a very good reason to be nice to ChatGPT, Wired fires up fake AI child porn debate, AI job losses hope, how companies use AI today.",RMD,0.023191,0.001893,Neutral
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2139057/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2023-08-22 13:43:00,"Investors continue to be optimistic about ResMed (RMD), backed by the continued demand for digital health solutions.",RMD,0.298437,0.209633,Somewhat-Bullish
"Respiratory Disposables Market to Reach US$ 1.8 billion by 2031, Expanding at a CAGR of 5.2%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33958477/respiratory-disposables-market-to-reach-us-1-8-billion-by-2031-expanding-at-a-cagr-of-5-2-tmr-repo,2023-08-21 09:47:41,"Wilmington, Delaware, United States, Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global respiratory disposable market is projected to flourish at a CAGR of 5.2% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 1.8 billion is anticipated for ...",RMD,0.042647,0.129395,Neutral
2 Stocks That Could Grow Your Portfolio Over the Next Decade,https://www.fool.com/investing/2023/08/15/stocks-could-grow-portfolio-over-next-decade/,2023-08-15 13:44:42,These two promising stocks could help your portfolio grow steadily over the long term.,RMD,0.262724,0.348113,Somewhat-Bullish
Here's Why We Think ResMed Stock Is Undervalued After An 18% Fall In A Month,https://www.forbes.com/sites/greatspeculations/2023/08/11/heres-why-we-think-resmed-stock-is-undervalued-after-an-18-fall-in-a-month/,2023-08-11 11:00:13,"ResMed (NYSE: RMD), a medical equipment company, has seen an 18% fall in a month, underperforming the broader S&P500 index, up 1%.",RMD,0.77496,0.031845,Neutral
"If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,000 Today - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/news/earnings/23/08/33719293/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-8-000-today,2023-08-10 18:00:20,"ResMed RMD has outperformed the market over the past 15 years by 6.38% on an annualized basis producing an average annual return of 14.92%. Currently, ResMed has a market capitalization of $26.05 billion.",RMD,0.983605,0.387251,Bullish
ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33578061/resmeds-q4-results-analysts-say-uncertain-market-dynamics-follow-amid-philips-re-en,2023-08-04 18:00:07,"ResMed Inc RMD posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67. Revenues increased 23% to $1.12 billion, in line with consensus, driven by increased demand for sleep and respiratory care devices and reduced competitive supply.",RMD,0.38489,0.0,Neutral
"ResMed's  ( RMD )  Q4 Earnings Miss, Revenues Beat Estimates",https://www.zacks.com/stock/news/2132820/resmeds-rmd-q4-earnings-miss-revenues-beat-estimates,2023-08-04 16:20:00,ResMed (RMD) records a robust sales performance in fiscal Q4 backed by the ongoing combined availability of cloud-connected AirSense 10 and AirSense 11 sleep devices.,RMD,0.2827,0.135512,Neutral
"Sleep apnea implants market size to grow by USD 2,82,442.79 thousand from 2022 to 2027 | Increasing prevalence of ... - PR Newswire",https://www.prnewswire.com/news-releases/sleep-apnea-implants-market-size-to-grow-by-usd-2-82-442-79-thousand-from-2022-to-2027--increasing-prevalence-of-sleep-apnea-and-respiratory-disorders-boost-the-market--technavio-301892627.html,2023-08-04 07:30:00,"Sleep apnea implants market size to grow by USD 2,82,442.79 thousand from 2022 to 2027 | Increasing prevalence of ... PR ...",RMD,0.041828,0.037782,Neutral
ResMed  ( RMD )  Misses Q4 Earnings Estimates,https://www.zacks.com/stock/news/2132300/resmed-rmd-misses-q4-earnings-estimates,2023-08-03 21:55:17,"ResMed (RMD) delivered earnings and revenue surprises of -4.19% and 0.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",RMD,0.400265,0.184135,Somewhat-Bullish
Why Earnings Season Could Be Great for ResMed  ( RMD ) ,https://www.zacks.com/stock/news/2131017/why-earnings-season-could-be-great-for-resmed-rmd,2023-08-02 12:48:00,ResMed (RMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,RMD,0.906257,0.608664,Bullish
"Portable Oxygen Concentrators Market to reach USD 4.0 billion by 2031, expanding at a CAGR of 10.6%: TMR Report",https://www.benzinga.com/pressreleases/23/08/g33499779/portable-oxygen-concentrators-market-to-reach-usd-4-0-billion-by-2031-expanding-at-a-cagr-of-10-6-,2023-08-01 16:30:00,"Wilmington, Delaware, United States, Aug. 01, 2023 ( GLOBE NEWSWIRE ) -- The global portable oxygen concentrators market is projected to flourish at a CAGR of 10.6% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 4.0 billion is anticipated for the market in 2031.",RMD,0.043108,0.138473,Neutral
"Stocks making the biggest moves midday: Coinbase, SoFi, DoorDash and more",https://www.cnbc.com/2023/08/01/stocks-making-the-biggest-moves-midday-coinbase-sofi-doordash-and-more.html,2023-08-01 16:03:14,These are the stocks posting the largest moves in midday trading.,RMD,0.053271,0.484054,Bullish
Here's How Much You Would Have Made Owning ResMed Stock In The Last 5 Years - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/earnings/23/07/33451828/heres-how-much-you-would-have-made-owning-resmed-stock-in-the-last-5-years,2023-07-28 21:30:26,"ResMed RMD has outperformed the market over the past 5 years by 5.93% on an annualized basis producing an average annual return of 16.1%. Currently, ResMed has a market capitalization of $32.78 billion.",RMD,0.983605,0.387251,Bullish
Publication Relating to a Transparency Notification,https://www.globenewswire.com/news-release/2023/07/27/2712738/0/en/Publication-Relating-to-a-Transparency-Notification.html,2023-07-27 20:30:00,"Mont-Saint-Guibert ( Belgium ) , July 27, 2023, 10.30pm CET / 4.30pm ET - In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) announces that it received a rectification of an earlier transparency ...",RMD,0.856646,0.230123,Somewhat-Bullish
Publication Relating to a Transparency Notification - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/07/g33430999/publication-relating-to-a-transparency-notification,2023-07-27 20:30:00,"Publication Relating to a Transparency Notification Mont-Saint-Guibert ( Belgium ) , July 27, 2023, 10.30pm CET / 4.30pm ET - In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA NYXH announces that it received a rectification of an earlier ...",RMD,0.807885,0.289183,Somewhat-Bullish
Looking Into ResMed's Recent Short Interest - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/short-sellers/23/07/33398453/looking-into-resmeds-recent-short-interest,2023-07-26 16:45:20,"ResMed's RMD short percent of float has risen 11.96% since its last report. The company recently reported that it has 1.33 million shares sold short, which is 1.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.34 days to cover their ...",RMD,0.224903,0.158881,Somewhat-Bullish
CerraCap Ventures Celebrates Successful Exit as ResMed Acquires Portfolio Company Somnoware Healthcare Systems Inc.,https://www.prnewswire.com/news-releases/cerracap-ventures-celebrates-successful-exit-as-resmed-acquires-portfolio-company-somnoware-healthcare-systems-inc-301880766.html,2023-07-19 10:03:00,CerraCap Ventures Celebrates Successful Exit as ResMed Acquires Portfolio Company Somnoware Healthcare ... PR ...,RMD,0.307924,0.478543,Bullish
Here's How Much $100 Invested In ResMed 20 Years Ago Would Be Worth Today - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/earnings/23/07/33185675/heres-how-much-100-invested-in-resmed-20-years-ago-would-be-worth-today,2023-07-11 14:00:39,"ResMed RMD has outperformed the market over the past 20 years by 8.89% on an annualized basis producing an average annual return of 16.6%. Currently, ResMed has a market capitalization of $31.89 billion.",RMD,0.983605,0.387251,Bullish
MONTAGE HEALTH SELECTS XEALTH TO DRIVE DIGITAL HEALTH STRATEGY,https://www.benzinga.com/pressreleases/23/07/g33180867/montage-health-selects-xealth-to-drive-digital-health-strategy,2023-07-11 12:02:00,"MONTEREY, Calif., and SEATTLE, July 11, 2023 ( GLOBE NEWSWIRE ) -- Xealth, the leader in enabling digital health at scale, today announced that Montage Health, a nonprofit family of organizations across Monterey County, Calif., is using Xealth's digital health platform system-wide to power its ...",RMD,0.055751,0.191949,Somewhat-Bullish
Peering Into ResMed's Recent Short Interest - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/short-sellers/23/07/33171241/peering-into-resmeds-recent-short-interest,2023-07-10 17:45:26,"ResMed's RMD short percent of float has fallen 28.57% since its last report. The company recently reported that it has 1.03 million shares sold short, which is 0.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.68 days to cover their ...",RMD,0.224903,0.085754,Neutral
ResMed  ( RMD )  Expands Solutions Portfolio With Somnoware Buyout,https://www.zacks.com/stock/news/2118047/resmed-rmd-expands-solutions-portfolio-with-somnoware-buyout,2023-07-07 13:35:00,ResMed (RMD) announces the acquisition of the Somnoware diagnostic management platform.,RMD,0.424139,0.490684,Bullish
"ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023 - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/pressreleases/23/07/g33139162/resmed-to-report-fourth-quarter-fiscal-2023-earnings-on-august-3-2023,2023-07-06 20:05:00,"SAN DIEGO, July 06, 2023 ( GLOBE NEWSWIRE ) -- ResMed RMDRMD ) ) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the New York Stock Exchange closes.",RMD,0.657566,0.466844,Bullish
"ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/pressreleases/23/07/g33122443/resmed-acquires-somnoware-a-leader-in-digital-sleep-and-respiratory-care-diagnostics-software,2023-07-05 20:05:00,"Expands ResMed's sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management platform is upstream of and complementary to ResMed's current post-testing AirView and Brightree offerings",RMD,0.567746,0.660114,Bullish
"Oxygen Cylinders and Concentrators Market to Exhibit 4.6% CAGR and Generate $6,658.5 Million By 2031 | Research Dive",https://www.benzinga.com/pressreleases/23/07/g33106327/oxygen-cylinders-and-concentrators-market-to-exhibit-4-6-cagr-and-generate-6-658-5-million-by-2031,2023-07-04 13:05:00,"New York, USA, July 04, 2023 ( GLOBE NEWSWIRE ) -- According to a report published by Research Dive, the global oxygen cylinders and concentrators market is projected to generate a revenue of $6,658.5 million and rise at a CAGR of 4.6% throughout the analysis period from 2022 to 2031.",RMD,0.064276,-0.06604,Neutral
"$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/news/earnings/23/06/33049309/1000-invested-in-this-stock-15-years-ago-would-be-worth-11-000-today,2023-06-28 19:30:49,"ResMed RMD has outperformed the market over the past 15 years by 8.78% on an annualized basis producing an average annual return of 17.38%. Currently, ResMed has a market capitalization of $31.55 billion.",RMD,0.983605,0.387251,Bullish
These Fund Yields Up To 13% And Leave ETFs In The Dust,https://www.forbes.com/sites/brettowens/2023/06/25/these-fund-yields-up-to-13-and-leave-etfs-in-the-dust/,2023-06-25 13:14:00,AI bubble? Bear market rally? I don't care because I see five dividends between 10.1% and 13.5%.,RMD,0.050096,0.087325,Neutral
ResMed  ( NYSE:RMD )  Downgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/06/22/resmed-nysermd-downgraded-to-hold-at-stocknews-com.html,2023-06-22 07:16:41,"StockNews.com downgraded shares of ResMed ( NYSE:RMD - Get Rating ) from a buy rating to a hold rating in a research report sent to investors on Wednesday. A number of other research firms have also recently issued reports on RMD. UBS Group initiated coverage on ResMed in a report on Monday, ...",RMD,0.722395,0.444728,Bullish
"Global Respiratory Devices and Equipment Market Report: Comprehensive Analysis, Forecast to 2031, and Future Trends - Dataintelo",https://www.prnewswire.com/news-releases/global-respiratory-devices-and-equipment-market-report-comprehensive-analysis-forecast-to-2031-and-future-trends---dataintelo-301852855.html,2023-06-16 06:54:00,"Global Respiratory Devices and Equipment Market Report: Comprehensive Analysis, Forecast to 2031, and Future ... PR ...",RMD,0.040348,0.092192,Neutral
ResMed's  ( RMD )  New Buyout Aids Growth Amid Rising Costs,https://www.zacks.com/stock/news/2108885/resmeds-rmd-new-buyout-aids-growth-amid-rising-costs,2023-06-15 14:03:00,ResMed's (RMD) respiratory care business witnesses continued customer uptake of bilevel and other non-invasive ventilator solutions worldwide.,RMD,0.404098,0.480685,Bullish
"If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/news/earnings/23/06/32822834/if-you-invested-100-in-this-stock-5-years-ago-you-would-have-200-today,2023-06-12 19:30:48,"ResMed RMD has outperformed the market over the past 5 years by 5.78% on an annualized basis producing an average annual return of 15.15%. Currently, ResMed has a market capitalization of $31.47 billion.",RMD,0.983605,0.387251,Bullish
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2106024/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2023-06-08 17:25:00,Investors continue to be optimistic about ResMed (RMD) backed by the continued demand for digital health solutions.,RMD,0.446457,0.498106,Bullish
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP,https://www.globenewswire.com/news-release/2023/06/08/2684787/0/en/PAP-Adherence-Lowers-ER-Visits-24-36-in-1-Year-for-People-with-Sleep-Apnea-and-Heart-Failure-ResMed-Studies-Presented-at-SLEEP.html,2023-06-08 13:00:00,"INDIANAPOLIS, June 08, 2023 ( GLOBE NEWSWIRE ) -- People with heart failure and obstructive sleep apnea ( OSA ) can significantly reduce hospitalizations and ER visits as well as related costs by being adherent on positive airway pressure ( PAP ) therapy, according to two studies supported by ...",RMD,0.536866,0.522535,Bullish
"Qualcomm Sponsoring EvoNexus Incubator Demo Day June 26th, 2023",https://www.prnewswire.com/news-releases/qualcomm-sponsoring-evonexus-incubator-demo-day-june-26th-2023-301845503.html,2023-06-07 21:37:00,Qualcomm Sponsoring EvoNexus Incubator Demo Day June 26th ... PR ...,RMD,0.092927,0.141115,Neutral
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference,https://www.globenewswire.com/news-release/2023/06/05/2682358/0/en/ResMed-Announces-Participation-in-the-Goldman-Sachs-44th-Annual-Global-Healthcare-Conference.html,2023-06-05 20:05:00,"SAN DIEGO, June 05, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, beginning at approximately ...",RMD,0.874686,0.467105,Bullish
ResMed  ( NYSE:RMD )  Lifted to Buy at StockNews.com,https://www.defenseworld.net/2023/06/03/resmed-nysermd-lifted-to-buy-at-stocknews-com.html,2023-06-03 05:20:46,"ResMed ( NYSE:RMD - Get Rating ) was upgraded by analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a note issued to investors on Saturday. Several other brokerages also recently commented on RMD. Mizuho started coverage on shares of ResMed in a report on Thursday, April 13th.",RMD,0.773157,0.459506,Bullish
ResMed Joins Elite List Of Stocks With 95-Plus Composite Rating,https://www.investors.com/ibd-data-stories/resmed-joins-elite-list-of-stocks-with-95-plus-composite-rating/,2023-06-02 07:00:00,"ResMed ( RMD ) saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 94 the day before. X The new score tells you the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.",RMD,0.52759,-0.00324,Neutral
ZBH vs. RMD: Which Stock Should Value Investors Buy Now?,https://www.zacks.com/stock/news/2100990/zbh-vs-rmd-which-stock-should-value-investors-buy-now,2023-05-29 15:40:10,ZBH vs. RMD: Which Stock Is the Better Value Option?,RMD,0.680677,0.608413,Bullish
"ResMed  ( NYSE:RMD )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/05/27/resmed-nysermd-downgraded-by-stocknews-com-to-hold.html,2023-05-27 09:57:56,"StockNews.com cut shares of ResMed ( NYSE:RMD - Get Rating ) from a buy rating to a hold rating in a report published on Friday morning. Other equities research analysts have also issued research reports about the stock. Mizuho began coverage on shares of ResMed in a research note on Thursday, ...",RMD,0.755278,0.459675,Bullish
Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/earnings/23/05/32602043/heres-how-much-you-would-have-made-owning-resmed-stock-in-the-last-10-years,2023-05-26 19:00:53,"ResMed RMD has outperformed the market over the past 10 years by 6.02% on an annualized basis producing an average annual return of 15.76%. Currently, ResMed has a market capitalization of $31.65 billion.",RMD,0.983605,0.387251,Bullish
A Bullish Sign Appears On ResMed's Chart - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/markets/23/05/32447087/a-bullish-sign-appears-on-resmeds-chart,2023-05-17 14:49:26,"If history is any guide, there may be good fortune ahead for shares of ResMed RMD. A so-called ""golden cross"" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.",RMD,0.459624,0.563976,Bullish
Nyxoah Reports First Quarter 2023 Financial and Operating Results,https://www.globenewswire.com/news-release/2023/05/16/2670416/0/en/Nyxoah-Reports-First-Quarter-2023-Financial-and-Operating-Results.html,2023-05-16 20:05:00,REGULATED INFORMATION ...,RMD,0.028868,0.099135,Neutral
Nyxoah Reports First Quarter 2023 Financial and Operating Results - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/05/g32432600/nyxoah-reports-first-quarter-2023-financial-and-operating-results,2023-05-16 20:05:00,"Mont-Saint-Guibert, Belgium - May 16, 2023 10:05pm CET / 4:05pm ET - Nyxoah SA NYXH ( ""Nyxoah"" or the ""Company"" ) , a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ( OSA ) , today reported financial and ...",RMD,0.028558,0.0,Neutral
"Electronic Arts, TD SYNNEX And 2 Other Stocks Insiders Are Selling - Lincoln Educational Servs  ( NASDAQ:LINC ) , Electronic Arts  ( NASDAQ:EA ) ",https://www.benzinga.com/news/23/05/32391247/electronic-arts-td-synnex-and-2-other-stocks-insiders-are-selling,2023-05-15 12:29:01,"The Nasdaq index closed lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock.",RMD,0.387674,0.304509,Somewhat-Bullish
ResMed Chief Financial Officer Trades $794K In Company Stock - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/23/05/32344462/resmed-chief-financial-officer-trades-794k-in-company-stock,2023-05-11 15:08:18,"Brett Sandercock, Chief Financial Officer at ResMed RMD, reported a large insider sell on May 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Sandercock sold 3,426 shares of ResMed.",RMD,0.519739,0.286283,Somewhat-Bullish
"ResMed  ( NYSE:RMD )  Upgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/05/09/resmed-nysermd-upgraded-to-buy-at-stocknews-com.html,2023-05-09 09:40:58,StockNews.com upgraded shares of ResMed ( NYSE:RMD - Get Rating ) from a hold rating to a buy rating in a report released on Monday morning. A number of other research analysts have also recently weighed in on the company.,RMD,0.729762,0.4409,Bullish
Mechanical Ventilator Market Size Report 2023-2032: Market Growth Drivers And Opportunities - By The Business Research Company,https://www.prnewswire.com/news-releases/mechanical-ventilator-market-size-report-2023-2032-market-growth-drivers-and-opportunities--by-the-business-research-company-301814525.html,2023-05-04 10:40:00,Mechanical Ventilator Market Size Report 2023-2032: Market ... PR ...,RMD,0.0699,-0.039128,Neutral
Top-Rated Stocks: LeMaitre Vascular Sees Composite Rating Climb To 97,https://www.investors.com/ibd-data-stories/top-rated-stocks-lemaitre-vascular-sees-composite-rating-climb-to-97/,2023-05-04 07:00:00,Top-Rated Stocks: LeMaitre Vascular Sees Composite Rating Climb ... Investor's Business Daily ...,RMD,0.306963,0.134904,Neutral
IBD Rating Upgrades: Alcon Flashes Improved Technical Strength,https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-alcon-flashes-improved-technical-strength/,2023-05-04 07:00:00,"On Thursday, Alcon ( ALC ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 65 to 77. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",RMD,0.271274,0.0,Neutral
"ResMed Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/resmed-clears-technical-benchmark-hitting-80-plus-rs-rating-2/,2023-05-03 07:00:00,"The Relative Strength ( RS ) Rating for ResMed ( RMD ) jumped into a new percentile Wednesday, with an increase from 80 to 83. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",RMD,0.308891,0.482591,Bullish
Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge,https://www.investors.com/research/growth-stock-resmed-breaks-out-on-record-earnings-sleep-apnea-device-sales-surge/,2023-05-01 19:15:00,Sleep-Apnea Growth Stock Breaks Out On Record Earnings. Device ... Investor's Business Daily ...,RMD,0.617765,0.454898,Bullish
What's Going On With ResMed  ( RMD )  Stock Today - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/04/32089607/whats-going-on-with-resmed-stock-today,2023-04-28 19:31:12,"ResMed Inc RMD posted Q3 profits of $247.8 million, with adjusted EPS of $1.68, up from $1.32 a year ago, beating the consensus of $1.59. Revenues increased 29% to $1.12 billion, as continued growth reflects a ramp-up in production due to growing demand.",RMD,0.693563,0.332856,Somewhat-Bullish
"AAPL Stock Ramps Higher Ahead Of Quarterly Results. Wall Street Eyes Reports From DraftKings, Arista Networks",https://www.investors.com/research/earnings-preview/aapl-stock-ramps-higher-quarterly-results-wall-street-eyes-reports-draftkings-arista-networks/,2023-04-28 15:38:00,"Apple, DraftKings, Arista Headline Busy Earnings Calendar Investor's Business Daily ...",RMD,0.067919,0.155003,Somewhat-Bullish
ResMed  ( RMD )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086818/resmed-rmd-q3-earnings-and-revenues-surpass-estimates,2023-04-28 13:16:00,"ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.",RMD,0.369685,0.174758,Somewhat-Bullish
ResMed  ( RMD )  Q3 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2086450/resmed-rmd-q3-earnings-and-revenues-beat-estimates,2023-04-27 21:45:17,"ResMed (RMD) delivered earnings and revenue surprises of 7.01% and 7.95%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",RMD,0.405651,0.279965,Somewhat-Bullish
Uptempo Welcomes New Chief Customer Officer to Help Global Enterprises Adopt Marketing Business Acceleration,https://www.prnewswire.com/news-releases/uptempo-welcomes-new-chief-customer-officer-to-help-global-enterprises-adopt-marketing-business-acceleration-301806317.html,2023-04-25 13:00:00,Uptempo Welcomes New Chief Customer Officer to Help Global ... PR ...,RMD,0.111488,0.199965,Somewhat-Bullish
Publication Relating to Transparency Notifications - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/04/g31924966/publication-relating-to-transparency-notifications,2023-04-20 20:30:00,"Mont-Saint-Guibert ( Belgium ) , April 20, 2023, 10.30pm CET / 4.30pm ET - In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA NYXH announces that it received two transparency notifications as detailed below.",RMD,0.630923,0.243052,Somewhat-Bullish
Publication Relating to Transparency Notifications,https://www.globenewswire.com/news-release/2023/04/20/2651586/0/en/Publication-Relating-to-Transparency-Notifications.html,2023-04-20 20:30:00,"Mont-Saint-Guibert ( Belgium ) , April 20, 2023, 10.30pm CET / 4.30pm ET - In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) announces that it received two transparency notifications as detailed below.",RMD,0.614086,0.172254,Somewhat-Bullish
Home Medical Equipment Market in United States Is Expected to Reach $20.39 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/04/g31917234/home-medical-equipment-market-in-united-states-is-expected-to-reach-20-39-billion-by-2031-allied-m,2023-04-20 15:01:40,"Portland, OR, April 20, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the U.S. home medical equipment market generated $12.38 billion in 2021, and is estimated to reach $20.39 billion by 2031, witnessing a CAGR of 5.1% from 2022 to 2031.",RMD,0.041039,-0.016685,Neutral
"If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today - ResMed  ( NYSE:RMD ) ",https://www.benzinga.com/news/earnings/23/04/31900352/if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-2-300-today,2023-04-19 19:31:05,"ResMed RMD has outperformed the market over the past 5 years by 8.64% on an annualized basis producing an average annual return of 18.16%. Currently, ResMed has a market capitalization of $32.67 billion.",RMD,0.983605,0.387251,Bullish
ResMed Chief Administrative Officer and Global General Counsel to Retire - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/03/g31595578/resmed-chief-administrative-officer-and-global-general-counsel-to-retire,2023-03-30 20:05:00,"ResMed to conduct an internal search for a successor general counsel Amy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed's executive leadership team",RMD,0.636698,0.472481,Bullish
Nyxoah Announces a $15 Million Private Placement Financing - Nyxoah  ( NASDAQ:NYXH ) ,https://www.benzinga.com/pressreleases/23/03/g31482165/nyxoah-announces-a-15-million-private-placement-financing,2023-03-23 20:05:00,Nyxoah Announces a $15 Million Private Placement Financing,RMD,0.030799,0.104079,Neutral
3 Incredible Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/03/22/3-incredible-growth-stocks-to-buy-right-now/,2023-03-22 12:45:00,These mid-cap growth stocks could deliver market-beating returns in 2023 and beyond.,RMD,0.312158,0.258968,Somewhat-Bullish
$100 Invested In ResMed 5 Years Ago Would Be Worth This Much Today - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/earnings/23/03/31399739/100-invested-in-resmed-5-years-ago-would-be-worth-this-much-today,2023-03-17 15:31:04,"ResMed RMD has outperformed the market over the past 5 years by 8.7% on an annualized basis producing an average annual return of 16.27%. Currently, ResMed has a market capitalization of $30.65 billion.",RMD,0.983605,0.387251,Bullish
Reasons Why You Should Retain ResMed  ( RMD )  Stock For Now,https://www.zacks.com/stock/news/2066786/reasons-why-you-should-retain-resmed-rmd-stock-for-now,2023-03-16 14:49:00,Investors are optimistic about ResMed's (RMD) Increased demand for its digital health solution.,RMD,0.302553,0.42263,Bullish
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/03/g31369701/resmed-announces-participation-in-the-2023-keybanc-life-sciences-medtech-investor-forum,2023-03-15 20:19:09,"SAN DIEGO, March 15, 2023 ( GLOBE NEWSWIRE ) -- ResMed RMDRMD ) ) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. ( Eastern ...",RMD,0.491878,0.399521,Bullish
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum,https://www.globenewswire.com/news-release/2023/03/15/2628184/0/en/ResMed-Announces-Participation-in-the-2023-KeyBanc-Life-Sciences-MedTech-Investor-Forum.html,2023-03-15 20:19:00,"SAN DIEGO, March 15, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximately 3:45 p.m. ...",RMD,0.88837,0.520613,Bullish
State of play: Remote respiratory monitoring,https://www.axios.com/pro/health-tech-deals/2023/03/15/state-of-play-remote-respiratory-monitoring,2023-03-15 14:12:44,"Several remote patient monitoring companies focused on respiratory health have attracted investor and acquisition interest in recent years. • Propeller Health, developer of a digital inhaler designed to track medication adherence, in 2019 was acquired by ResMed ( NYSE: RMD ) for $242.9 million.",RMD,0.733479,0.0,Neutral
58 percent Indians consider snoring as a sign of good sleep | The Financial Express,https://www.financialexpress.com/healthcare/wellness/58-percent-indians-consider-snoring-as-a-sign-of-good-sleep/3010335/,2023-03-15 09:10:00,58 percent Indians consider snoring as a sign of good sleep The Financial Express ...,RMD,0.354572,0.21885,Somewhat-Bullish
A top GE HealthCare marketing exec reveals the brand strategy that helped the GE spinoff become a $35 billion company two months after going public,https://www.businessinsider.com/top-ge-healthcare-marketing-exec-talks-brand-launch-2023-3,2023-03-13 12:00:00,Top GE HealthCare Marketing Exec Talks Brand Launch - Business Insider ...,RMD,0.083251,0.060233,Neutral
ResMed's Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep,https://www.globenewswire.com/news-release/2023/03/13/2625549/0/en/ResMed-s-Annual-Global-Sleep-Survey-Finds-8-in-10-Adults-Experience-Signs-of-Disruption-Related-to-Their-Quality-of-Sleep.html,2023-03-13 11:00:00,"SAN DIEGO, March 13, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) announced today the results from its 2023 Global Sleep Survey in conjunction with National Sleep Awareness Week ( March 12-18 ) and World Sleep Day ( March 17 ) to raise awareness for the importance of sleep as a key ...",RMD,0.335266,0.222137,Somewhat-Bullish
Children's Wisconsin Uses Xealth to Digitally Engage Patients and Families,https://www.benzinga.com/pressreleases/23/03/g31255994/childrens-wisconsin-uses-xealth-to-digitally-engage-patients-and-families,2023-03-08 13:10:00,"MILWAUKEE and SEATTLE, March 08, 2023 ( GLOBE NEWSWIRE ) -- Xealth, the leader in enabling digital health at scale, today announced that Children's Wisconsin, Wisconsin's only independent healthcare system dedicated solely to the health and well-being of children, is using Xealth's digital ...",RMD,0.052226,0.184603,Somewhat-Bullish
EYE vs. RMD: Which Stock Should Value Investors Buy Now?,https://www.zacks.com/stock/news/2062629/eye-vs-rmd-which-stock-should-value-investors-buy-now,2023-03-07 16:40:11,EYE vs. RMD: Which Stock Is the Better Value Option?,RMD,0.645091,0.474365,Bullish
Earn Massive 10%+ Yields With These 5 Funds,https://www.forbes.com/sites/brettowens/2023/02/26/earn-massive-10-yields-with-these-5-funds/,2023-02-26 12:30:00,Bull or bear? Who cares when we can collect dividends between 10.1% and 11.8%.,RMD,0.050359,0.067786,Neutral
Reasons Why You Should Retain ResMed  ( RMD )  Stock For Now,https://www.zacks.com/stock/news/2054762/reasons-why-you-should-retain-resmed-rmd-stock-for-now,2023-02-15 16:07:00,Investors are optimistic about ResMed (RMD) owing to the increased demand for its sleep and respiratory care devices.,RMD,0.193078,0.316494,Somewhat-Bullish
"Top Research Reports for Chevron, Novo Nordisk & Amgen",https://www.zacks.com/research-daily/2054049/top-research-reports-for-chevron-novo-nordisk-amgen,2023-02-14 16:10:00,"Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).",RMD,0.134968,0.137293,Neutral
"ResMed's  ( RMD )  Mask Sales Drive Growth, Margin Issue Lingers",https://www.zacks.com/stock/news/2054009/resmeds-rmd-mask-sales-drive-growth-margin-issue-lingers,2023-02-14 14:32:00,ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.,RMD,0.400417,0.29431,Somewhat-Bullish
Ventilators Market Size  ( $9.09 Billion by 2028 )  Lead by Combined Mode Ventilation  ( 10.2% CAGR )  - Growth Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g30834689/ventilators-market-size-9-09-billion-by-2028-lead-by-combined-mode-ventilation-10-2-cagr-growth-re,2023-02-09 14:40:21,"New York, Feb. 09, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on ""Ventilators Market Size, Share, Growth and Trend Forecast to 2028 - COVID-19 Impact and Global Analysis by Mobility ( Intensive Care Ventilators and Portable/Transportable Ventilators ) , ...",RMD,0.03178,0.112241,Neutral
$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/news/earnings/23/02/30816676/100-invested-in-resmed-10-years-ago-would-be-worth-this-much-today,2023-02-08 16:34:28,"ResMed RMD has outperformed the market over the past 10 years by 7.12% on an annualized basis producing an average annual return of 17.6%. Currently, ResMed has a market capitalization of $32.43 billion.",RMD,0.983605,0.387251,Bullish
Southern Illinois Healthcare Selects Xealth to Digitally Engage Patients,https://www.benzinga.com/pressreleases/23/02/g30807621/southern-illinois-healthcare-selects-xealth-to-digitally-engage-patients,2023-02-08 13:03:00,"CARBONDALE, Ill., and SEATTLE, Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Xealth, the leader in enabling digital health at scale, today announced that Southern Illinois Healthcare ( SIH ) , a not-for-profit health system serving the southernmost counties of Illinois, is utilizing Xealth's digital ...",RMD,0.059194,0.185013,Somewhat-Bullish
"Global mHealth and Home Monitoring Market Analysis Report 2023: Focus on Cardiac Rhythm, Sleep Therapy, Telehealth, ECG Monitoring, Glucose Monitoring, and Medication Compliance - Forecast to 2027",https://www.prnewswire.com/news-releases/global-mhealth-and-home-monitoring-market-analysis-report-2023-focus-on-cardiac-rhythm-sleep-therapy-telehealth-ecg-monitoring-glucose-monitoring-and-medication-compliance---forecast-to-2027-301739198.html,2023-02-06 10:40:00,Global mHealth and Home Monitoring Market Analysis Report 2023 ... PR ...,RMD,0.053749,-0.001993,Neutral
Enovis Sees Relative Strength Rating Improve To 79,https://www.investors.com/ibd-data-stories/enovis-sees-relative-strength-rating-improve-to-79/,2023-02-01 08:00:00,"In a welcome move, Enovis ( ENOV ) saw its Relative Strength Rating rise from 70 to 79 on Wednesday. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique rating tracks market leadership with a 1 ( worst ) to 99 ( best ) score.",RMD,0.327366,0.0,Neutral
Exclusive: Aluna inhales $15M Series B for asthma monitoring,https://www.axios.com/pro/health-tech-deals/2023/01/31/aluna-raises-15-million-series-b-asthma-monitoring,2023-01-31 16:20:30,"Why it matters: Although dozens of apps and devices exist to help people with lung conditions manage their illness, few offer what Aluna aims to: a fully integrated, combined service that lets people see how they respond to medications in real time. • ""What we do is essentially what you'd do in ...",RMD,0.156461,0.250309,Somewhat-Bullish
"With 7.1% CAGR, Sleep Apnea Devices Market Size to Surpass USD 13.10 Billion by 2028",https://www.benzinga.com/pressreleases/23/01/g30642616/with-7-1-cagr-sleep-apnea-devices-market-size-to-surpass-usd-13-10-billion-by-2028,2023-01-31 13:52:16,"Pune, India, Jan. 31, 2023 ( GLOBE NEWSWIRE ) -- The global Sleep Apnea Devices Market size was valued at USD 8.55 billion in 2020. The market is projected to grow from USD 8.09 billion in 2021 to USD 13.10 billion by 2028, exhibiting a CAGR of 7.1% during the forecast period.",RMD,0.106541,0.174964,Somewhat-Bullish
Australia Market ends lower,https://www.business-standard.com/article/news-cm/australia-market-ends-lower-123013000431_1.html,2023-01-30 06:59:00,"At closing bell, the benchmark S&P/ASX200 index was down 12.13 points, or 0.16%, to 7,481.70. The broader All Ordinaries index declined 9.15 points, or 0.12%, to 7,700.40. Total 6 of 11 sectors ended lower along with the S&P/ASX 200 Index.",RMD,0.097457,0.2966,Somewhat-Bullish
ESLOY vs. RMD: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2045601/esloy-vs-rmd-which-stock-is-the-better-value-option,2023-01-27 16:40:10,Investors interested in Medical - Products stocks are likely familiar with EssilorLuxottica Unsponsored ADR ( ESLOY Quick QuoteESLOY - ) and ResMed ( RMD Quick QuoteRMD - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer ...,RMD,0.686739,0.539353,Bullish
"ResMed's  ( RMD )  Q2 Earnings Beat Estimates, Margins Falls",https://www.zacks.com/stock/news/2045559/resmeds-rmd-q2-earnings-beat-estimates-margins-falls,2023-01-27 15:40:00,"ResMed's (RMD) mask sales growth was strong across the globe, reflecting a post-COVID pandemic awareness about the importance and need for respiratory hygiene and respiratory health.",RMD,0.349153,0.280849,Somewhat-Bullish
ResMed  ( RMD )  Q2 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2045022/resmed-rmd-q2-earnings-and-revenues-surpass-estimates,2023-01-26 22:25:06,"ResMed (RMD) delivered earnings and revenue surprises of 3.75% and 3.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",RMD,0.399204,0.207657,Somewhat-Bullish
Hopeful Golden Cross Forms On ResMed's Chart,https://www.benzinga.com/markets/23/01/30586538/hopeful-golden-cross-forms-on-resmeds-chart,2023-01-26 14:48:06,"If history is any guide, there may be good fortune ahead for shares of ResMed RMD. A so-called ""golden cross"" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.",RMD,0.459624,0.563976,Bullish
Sleep Apnea Devices Market is expected to grow from USD 4.2 billion in 2022 to USD 7.2 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30531488/sleep-apnea-devices-market-is-expected-to-grow-from-usd-4-2-billion-in-2022-to-usd-7-2-billion-by-,2023-01-23 20:00:00,"Pune India, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the sleep apnea devices market is operating and is ...",RMD,0.024572,0.04607,Neutral
"Homecare oxygen concentrators market size to grow by USD 1,476.28 million from 2022 to 2027: Growth driven by increasing prevalence of respiratory diseases - Technavio",https://www.prnewswire.com/news-releases/homecare-oxygen-concentrators-market-size-to-grow-by-usd-1-476-28-million-from-2022-to-2027-growth-driven-by-increasing-prevalence-of-respiratory-diseases---technavio-301725661.html,2023-01-20 12:30:00,Homecare oxygen concentrators market size to grow by USD ... PR ...,RMD,0.070935,0.014051,Neutral
Berg Insight says 56.8 million patients worldwide are remotely monitored,https://www.investorideas.com/news/2023/biotech/01191Patients-Remotely-Monitored.asp,2023-01-19 18:04:31,Berg Insight says 56.8 million patients worldwide are remotely ... ...,RMD,0.062434,0.040037,Neutral
Parks Associates Events Examine Expansion in Streaming and Connected Health as Consumers Embrace Connected Home Ecosystem,https://www.prnewswire.com/news-releases/parks-associates-events-examine-expansion-in-streaming-and-connected-health-as-consumers-embrace-connected-home-ecosystem-301725849.html,2023-01-19 13:05:00,Parks Associates Events Examine Expansion in Streaming and ... PR ...,RMD,0.08183,0.0,Neutral
Parks Associates Events Examine Expansion in Streaming and Connected Health as Consumers Embrace Connected Home Ecosystem,https://www.benzinga.com/pressreleases/23/01/n30480944/parks-associates-events-examine-expansion-in-streaming-and-connected-health-as-consumers-embrace-c,2023-01-19 13:05:00,"Future of Video and Connected Health Summit feature speakers from Adeia, ECG, Comcast, Sinclair, OMRON, ResMed, and more",RMD,0.119235,0.0,Neutral
Alphabet robotics division Intrinsic lays off 20% of total workforce,https://www.business-standard.com/article/international/alphabet-robotics-division-intrinsic-lays-off-20-of-total-workforce-123011300298_1.html,2023-01-13 06:56:00,"Alphabet, Google's parent company, has joined tech giants laying off employees amid global macroeconomic conditions, and the company's ""Other Bets"" division is the first to be impacted, the media reported.",RMD,0.120431,0.087202,Neutral
"ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023",https://www.globenewswire.com/news-release/2023/01/12/2587925/0/en/ResMed-to-Report-Second-Quarter-Fiscal-2023-Earnings-on-January-26-2023.html,2023-01-12 14:00:00,"SAN DIEGO, Jan. 12, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday, January 26, 2023, after the New York Stock Exchange closes.",RMD,0.92044,0.527804,Bullish
"The Zacks Analyst Blog Highlights Home Depot, Merck, Bank of America, Elevance Health and ResMed",https://www.zacks.com/stock/news/2037675/the-zacks-analyst-blog-highlights-home-depot-merck-bank-of-america-elevance-health-and-resmed,2023-01-11 10:00:00,"Home Depot, Merck, Bank of America, Elevance Health and ResMed are included in this Analyst Blog.",RMD,0.129866,0.0,Neutral
"Top Analyst Reports for Home Depot, Merck & Bank of America",https://www.zacks.com/research-daily/2037339/top-analyst-reports-for-home-depot-merck-bank-of-america,2023-01-10 17:37:00,"Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Merck & Co., Inc. (MRK) and Bank of America Corporation (BAC).",RMD,0.111488,0.185503,Somewhat-Bullish
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference,https://www.globenewswire.com/news-release/2023/01/02/2581771/0/en/ResMed-Announces-Participation-in-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html,2023-01-02 21:05:00,"SAN DIEGO, Jan. 02, 2023 ( GLOBE NEWSWIRE ) -- ResMed ( NYSE: RMD, ASX: RMD ) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. ( Pacific Standard Time ) at the ...",RMD,0.885652,0.55052,Bullish
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference - ResMed  ( NYSE:RMD ) ,https://www.benzinga.com/pressreleases/23/01/g30251331/resmed-announces-participation-in-the-41st-annual-j-p-morgan-healthcare-conference,2023-01-02 21:05:00,"SAN DIEGO, Jan. 02, 2023 ( GLOBE NEWSWIRE ) -- ResMed RMDRMD ) ) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. ( Pacific Standard Time ) at the Westin St. ...",RMD,0.488777,0.421626,Bullish
